Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- OXB.LSE
- Price
- 279.00
- Stock movement up
- +0.50 (0.18%)
- Company name
- Oxford BioMedica PLC
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Biotechnology
- Market cap
- 29.56B
- Ent value
- 29.65B
- Price/Sales
- 210.60
- Price/Book
- 415.01
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 42.93%
- 3 year return
- -24.64%
- 5 year return
- -17.29%
- 10 year return
- -6.98%
Last updated: 2025-04-12
DIVIDENDS
OXB.LSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 210.60 |
| Price to Book | 415.01 |
| EV to Sales | 211.26 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 105.94M |
| EPS (TTM) | -1.81 |
| FCF per share (TTM) | -0.83 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 140.34M |
| Gross profit (TTM) | 57.68M |
| Operating income (TTM) | -218.29M |
| Net income (TTM) | -189.97M |
| EPS (TTM) | -1.81 |
| EPS (1y forward) | -0.16 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 41.10% |
| Operating margin (TTM) | -155.54% |
| Profit margin (TTM) | -135.36% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 81.41M |
| Net receivables | 25.66M |
| Total current assets | 138.88M |
| Goodwill | 0.00 |
| Intangible assets | 29.99M |
| Property, plant and equipment | 0.00 |
| Total assets | 244.97M |
| Accounts payable | 13.01M |
| Short/Current long term debt | 110.31M |
| Total current liabilities | 59.15M |
| Total liabilities | 173.75M |
| Shareholder's equity | 71.22M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -73.30M |
| Capital expenditures (TTM) | 17.07M |
| Free cash flow (TTM) | -87.38M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -266.74% |
| Return on Assets | -77.55% |
| Return on Invested Capital | -249.85% |
| Cash Return on Invested Capital | -114.92% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 268.50 |
| Daily high | 281.00 |
| Daily low | 268.50 |
| Daily Volume | 229K |
| All-time high | 6024.99 |
| 1y analyst estimate | 533.25 |
| Beta | 1.05 |
| EPS (TTM) | -1.81 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 28 Apr 2025 |
Downside potential
Loading...
Downside potential data
| OXB.LSE | S&P500 | |
| Current price drop from All-time high | -95.37% | -12.89% |
| Highest price drop | -98.90% | -56.47% |
| Date of highest drop | 22 Jul 2013 | 9 Mar 2009 |
| Avg drop from high | -84.17% | -11.07% |
| Avg time to new high | 986 days | 12 days |
| Max time to new high | 6335 days | 1805 days |
COMPANY DETAILS
Marketcap
29.56B
Marketcap category
Large-cap
Description
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.
Employees
834
Website
Investor relations
-
SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found